Neurofibromin, encoded by NF1 gene, is a GTPase activating protein for RAS with 2818 amino acids. It ubiquitously expresses in multiple organ cells and mostly plays downregulating role in RAS-related signaling pathway (Cichowski & Jacks, 2001;Korf, 2013;Scheffzek & Welti, 2012). The human NF1 gene is located on chromosome 17q11.2, consisting of 57 exons and four alternatively spliced exons, spanning 282 kb of DNA (Viskochil et al., 1990). Linkage studies showed that loss-of-function mutations in the NF1 gene are causative of Neurofibromatosis type 1(NF1) (OMIM 162200), which is an autosomal dominant inherited disease and characterized by evolving tumors and nontumor manifestations. The most common and histologically benign tumor is neurofibroma, which may affect derm, spine, central nervous system (Lisch nodules in iris mostly) or extend along the nerve and form the plexiform neurofibromas ultimately. 10% adult patients with NF1 have high risks for malignant peripheral nerve sheath tumors (MPNSTs), especially in patients